332 related articles for article (PubMed ID: 18977352)
1. Involvement of Sema4A in the progression of experimental autoimmune myocarditis.
Makino N; Toyofuku T; Takegahara N; Takamatsu H; Okuno T; Nakagawa Y; Kang S; Nojima S; Hori M; Kikutani H; Kumanogoh A
FEBS Lett; 2008 Nov; 582(28):3935-40. PubMed ID: 18977352
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of CCR5 in experimental autoimmune myocarditis and reduced severity induced by anti-CCR5 monoclonal antibody.
Gong X; Feng H; Zhang S; Yu Y; Li J; Wang J; Guo B
J Mol Cell Cardiol; 2007 Apr; 42(4):781-91. PubMed ID: 17362985
[TBL] [Abstract][Full Text] [Related]
3. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
Blyszczuk P; Kania G; Dieterle T; Marty RR; Valaperti A; Berthonneche C; Pedrazzini T; Berger CT; Dirnhofer S; Matter CM; Penninger JM; Lüscher TF; Eriksson U
Circ Res; 2009 Oct; 105(9):912-20. PubMed ID: 19762681
[TBL] [Abstract][Full Text] [Related]
4. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17.
Rangachari M; Mauermann N; Marty RR; Dirnhofer S; Kurrer MO; Komnenovic V; Penninger JM; Eriksson U
J Exp Med; 2006 Aug; 203(8):2009-19. PubMed ID: 16880257
[TBL] [Abstract][Full Text] [Related]
5. The osteopontin - CD44 pathway is superfluous for the development of autoimmune myocarditis.
Abel B; Kurrer M; Shamshiev A; Marty RR; Eriksson U; Günthert U; Kopf M
Eur J Immunol; 2006 Feb; 36(2):494-9. PubMed ID: 16402410
[TBL] [Abstract][Full Text] [Related]
6. MyD88 signaling controls autoimmune myocarditis induction.
Marty RR; Dirnhofer S; Mauermann N; Schweikert S; Akira S; Hunziker L; Penninger JM; Eriksson U
Circulation; 2006 Jan; 113(2):258-65. PubMed ID: 16401773
[TBL] [Abstract][Full Text] [Related]
7. Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1/Th2 regulation in Sema4A-deficient mice.
Kumanogoh A; Shikina T; Suzuki K; Uematsu S; Yukawa K; Kashiwamura S; Tsutsui H; Yamamoto M; Takamatsu H; Ko-Mitamura EP; Takegahara N; Marukawa S; Ishida I; Morishita H; Prasad DV; Tamura M; Mizui M; Toyofuku T; Akira S; Takeda K; Okabe M; Kikutani H
Immunity; 2005 Mar; 22(3):305-16. PubMed ID: 15780988
[TBL] [Abstract][Full Text] [Related]
8. Quantification and characterization of myosin peptide-specific CD4+ T cells in autoimmune myocarditis.
Maier R; Miller S; Kurrer M; Krebs P; de Giuli R; Kremer M; Scandella E; Ludewig B
J Immunol Methods; 2005 Sep; 304(1-2):117-25. PubMed ID: 16125195
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of myocarditis and dilated cardiomyopathy.
Cihakova D; Rose NR
Adv Immunol; 2008; 99():95-114. PubMed ID: 19117533
[TBL] [Abstract][Full Text] [Related]
10. Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis.
Lee JH; Kim TH; Park HE; Lee EG; Jung NC; Song JY; Seo HG; Seung KB; Chang K; Lim DS
Cardiovasc Res; 2014 Feb; 101(2):203-10. PubMed ID: 24189626
[TBL] [Abstract][Full Text] [Related]
11. Chronic myocarditis induced by T cells reactive to a single cardiac myosin peptide: persistent inflammation, cardiac dilatation, myocardial scarring and continuous myocyte apoptosis.
Ratcliffe NR; Hutchins J; Barry B; Hickey WF
J Autoimmun; 2000 Nov; 15(3):359-67. PubMed ID: 11040076
[TBL] [Abstract][Full Text] [Related]
12. Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis.
Ohshima M; Yamahara K; Ishikane S; Harada K; Tsuda H; Otani K; Taguchi A; Miyazato M; Katsuragi S; Yoshimatsu J; Kodama M; Kangawa K; Ikeda T
J Mol Cell Cardiol; 2012 Sep; 53(3):420-8. PubMed ID: 22796574
[TBL] [Abstract][Full Text] [Related]
13. CD69 limits the severity of cardiomyopathy after autoimmune myocarditis.
Cruz-Adalia A; Jiménez-Borreguero LJ; Ramírez-Huesca M; Chico-Calero I; Barreiro O; López-Conesa E; Fresno M; Sánchez-Madrid F; Martín P
Circulation; 2010 Oct; 122(14):1396-404. PubMed ID: 20855659
[TBL] [Abstract][Full Text] [Related]
14. IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis.
Yang S; Li W; Liu W; Gao C; Zhou B; Li S; Li Y; Kong Y
Clin Immunol; 2006 Oct; 121(1):63-73. PubMed ID: 16904381
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune myocarditis does not require B cells for antigen presentation.
Malkiel S; Factor S; Diamond B
J Immunol; 1999 Nov; 163(10):5265-8. PubMed ID: 10553048
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with Flt3L-induced CD8α+ dendritic cells prevents CD4+ T helper cell-mediated experimental autoimmune myocarditis.
Valaperti A; Nishii M; Germano D; Liu PP; Eriksson U
Vaccine; 2013 Oct; 31(42):4802-11. PubMed ID: 23948227
[TBL] [Abstract][Full Text] [Related]
17. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2.
Kumanogoh A; Marukawa S; Suzuki K; Takegahara N; Watanabe C; Ch'ng E; Ishida I; Fujimura H; Sakoda S; Yoshida K; Kikutani H
Nature; 2002 Oct; 419(6907):629-33. PubMed ID: 12374982
[TBL] [Abstract][Full Text] [Related]
18. The role of the ICOS/B7RP-1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis.
Usui Y; Akiba H; Takeuchi M; Kezuka T; Takeuchi A; Hattori T; Okunuki Y; Yamazaki T; Yagita H; Usui M; Okumura K
Eur J Immunol; 2006 Nov; 36(11):3071-81. PubMed ID: 17039566
[TBL] [Abstract][Full Text] [Related]
19. Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-β therapy in multiple sclerosis.
Nakatsuji Y; Okuno T; Moriya M; Sugimoto T; Kinoshita M; Takamatsu H; Nojima S; Kimura T; Kang S; Ito D; Nakagawa Y; Toyofuku T; Takata K; Nakano M; Kubo M; Suzuki S; Matsui-Hasumi A; Uto-Konomi A; Ogata A; Mochizuki H; Sakoda S; Kumanogoh A
J Immunol; 2012 May; 188(10):4858-65. PubMed ID: 22491253
[TBL] [Abstract][Full Text] [Related]
20. Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice.
Tajiri K; Shimojo N; Sakai S; Machino-Ohtsuka T; Imanaka-Yoshida K; Hiroe M; Tsujimura Y; Kimura T; Sato A; Yasutomi Y; Aonuma K
Cardiovasc Drugs Ther; 2013 Oct; 27(5):413-24. PubMed ID: 23722419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
